Lonza
Karen Wolfrom is an experienced regulatory affairs professional with a strong background in the biotechnology and vaccine sectors. Currently serving as the Global Head of Regulatory Affairs at Lonza, Wolfrom has held multiple leadership roles including Head of Regulatory Affairs for Cell and Gene Technologies. Prior experience includes positions at DynPort Vaccine Company LLC, where Karen progressed from Project Manager to Director of Regulatory Affairs, overseeing technical development for various vaccines. Additionally, Wolfrom has worked as a Biologics Development Manager at AVANT Immunotherapeutics and as a Research Associate at Virus Research Institute. Wolfrom holds a Master’s degree in Animal Science/Microbiology and a teaching certification from the University of Rhode Island.
This person is not in any teams
This person is not in any offices
Lonza
68 followers
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The Life Science Ingredients division comprises a range of products for applications in nutrition, hygiene, preservation, water treatment, materials protection, and other industrial markets. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics.